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Introduction
CD4 + T cell phenotypes can be defined according to the pattern of cytokines secreted 7 .
Type 1 immunity relies on the generation of Th1 cells, whose hallmark cytokine is interferon-gamma (IFN-γ) 1 . Th2 cells produce a different spectrum of cytokines including interleukin-4 (IL-4) and interleukin-5 (IL-5) and are important in the generation of Type 2 immunity 7 . T-bet is a T-box transcription factor essential to Th1 cell generation and effector function 8 . Recently, its expression has also been described NK cells, dendritic cells and CD8 + cells [9] [10] [11] . T-bet directly transactivates the IFN-γ specific genes, particularly IFN-γ and its known targets 8, 9, 13 . Animals deficient in T-bet demonstrate a marked reduction in severity to a number of inflammatory diseases, including SLE, colitis, diabetes, hepatitis and arthritis, with a number of different abnormalities in effector function described in CD4 + and CD8 + cells [14] [15] [16] [17] [18] . However, it has been difficult to dissect the precise mechanisms of this protection, as many cell types in the immune system express T-bet. Furthermore, given its function as a master regulator of T cell lineage commitment, it is likely to direct the transcription of many genes involved in both cytokine production and other effector pathways.
For personal use only. by on . www.bloodjournal.org From 4 Effector Th1 and Th2 cells differ profoundly in their migratory properties 3, [19] [20] [21] . Th1 cells migrate to sites of inflammatory immune responses, whereas Th2 cells migrate predominantly to mucosal sites in the settings of allergy or helminth infection. E-and Pselectin ligands are expressed mainly on Th1 cells, being absent on naïve T cells and greatly reduced on Th2 cells when polarized in vitro 22 . However a recent report has shown binding of selectin-Ig fusion proteins in vivo to cells that express cytokines other than IFN-γ 23 , suggesting additional complexity. The initial step in Th1 cell recruitment is binding to P-and E-selectin expressed on activated vascular endothelium, interactions mediated mostly by the leucoyte ligand P-selectin glycoprotein ligand-1 (PSGL-1) 5, 24 .
Interestingly, PSGL-1 undergoes further enzymatic post-translational modification including core-2-glycosylation, fucosylation and tyrosine sulfation, all of which are required to produce a functional selectin ligand 25 . Upregulation of these selectin ligands has thus far been ascribed to the actions of IL-12 on activated lymphocytes, largely in a STAT4 dependent manner 22, 26 . Chemokines also play critical roles in T cell recruitment by mediating both the transition from selectin-dependent rolling to integrin-mediated firm adhesion 27 , as well as the subsequent locomotion and transendothelial migration of T cells 28 . Differential expression of chemokine receptors plays a key part in the process of T cell migration to inflammatory sites. The chemokine receptors CXCR3 and CCR5
are preferentially expressed on Th1 rather than Th2 T cells and, in addition to P-and Eselectin, are thought to be responsible for the specific recruitment of Th1 cells to inflammatory sites 29, 30 . Other chemokine receptors (e.g., CCR4, CCR10 and CCR9)
have also been described to mediate tissue specific homing, although not necessarily in a Th1 specific manner 6 . In contrast, other lymphocyte adhesion molecules implicated in the adhesion cascade, in particular the β 1 and β 2 integrins, LFA-1 and VLA-4, have not The resistance of T-bet deficient (T-bet -/-) mice to inflammatory diseases is characterized by a lack of T cell infiltration at pathologic sites 15, 16, 31 . For example, adoptively transferred T-bet -/-CD4 + T cells do not migrate to the intestine in SCID mice 15 . However, most of the disease models studied in this context have relied critically upon intact effector function for expression of disease and as such it has been impossible to study T cell trafficking in isolation. These observations led us to investigate the hypothesis that, in addition to cytokine secretion, T-bet directly controls a specific T cell migratory program. 
Methods

Mice.
T-bet -/-mice 14 were backcrossed onto the BALB/c strain for >10 generations and crossed onto the DO11.10 TCR-Tg strain. All DO11.10 mice and DO11.10 x T-bet -/-mice were heterozygous for the TCR transgene. T-bet CD2-Tg mice were generated as described and maintained on the BALB/c background 32 . BALB/c IFN-γ -/-mice (Jackson Laboratories) were crossed with the T-bet -/-strain to generate the T-bet -/-x IFN-γ -/-strain. Mice were housed in a specific pathogen free barrier unit at the Harvard School of Public Health. Handling of mice and experimental procedures were in accordance with institutional requirements for animal care and use. Mice were used at 4-6 weeks of age.
Cell preparation.
Primary lymph node (LN) CD4 + T cells were prepared either by positive selection with magnetic beads (Miltenyi, USA) as previously described 13 . T cells (>95% pure as assessed by flow cytometry) were stimulated with plate bound anti-CD3 and anti-CD28
antibodies (2µg/ml; Pharmingen) or with OVA peptide and syngeneic splenocytes in experiments using cells from DO11.10 animals. Th0, Th1 and Th2 polarising conditions were as previously described 13 . T cells were used at day 4-5 following primary stimulation. 
Adoptive transfer.
Adoptive transfers were performed as described 19 . Briefly, DO11.10 and DO11. 
Flow chamber assays.
The interactions of CD4 + T cells with immobilized P-and E-selectin were examined under conditions of fluid shear in a parallel plate flow chamber as previously described 22 . For assessment of chemokine-triggered adhesion to EC, cardiac EC were isolated and used as previously described 33 . All P-selectin interactions were blocked by the addition of an anti-PSGL-1 polyclonal antibody to the T cells (not shown). 
Sulfation assays.
Assays for tyrosine sulfation were performed as described 45 . by SDS-PAGE and sulfation was visualised by autoradiography.
Real time PCR.
Total RNA was extracted from CD4 + T cells with TRIzol solution (Invitrogen, Carlsbarg CA) and reverse transcription carried out with the iScript cDNA synthesis kit (Biorad, Hercules CA). The amount of amplicon generated was monitored with an Applied Biosystems 7700 (Applied Biosystems, Foster city, CA) apparatus. A specific probe labeled with both a reporter and a quencher dye was added into the Taqman PCR mix (Applied Biosystems) at the beginning of the reaction. The sequences of the primers and Taqman probes used in this study are available on request. Cycle number was normalised to β-actin.
Retroviral transduction.
T-bet and control retroviruses were produced and titred as described 8 . Briefly, CD4 + T cells from WT, T-bet -/-and T-bet -/-x IFN-γ -/-mice were activated with anti-CD3 and anti-CD28 and spin infected with retrovirus after 36 hours in the presence of 4 µg/ml polybrene. Fresh medium was added 24 hours later and the cells were either sorted by GFP expression and/or used for flow cytometric and transwell analysis at 5 days. The transduction efficiencies were typically 40-60% as assessed by GFP expression and this level of expression was the same between empty and T-bet expressing retrovirus.
Transwell assays.
Transwell assays were performed in 24 well plates with 5µm transwells that had been blocked with fibronectin (Corning, USA). 
Results
Reduced in vivo migration of T-cells from T-bet -/-mice.
In order to establish whether T-cell migration was impaired in these mice, we assessed the recruitment of adoptively transferred CD4 + T cells to a peripheral inflammatory site in vivo. Firstly, antigen specific TCR transgenic T cells (DO11.10 and DO11.10 x T-bet -/-) were generated in vitro and assessed for the expression of certain well-described adhesion molecules. T-bet -/-Th1 and Th2 cells demonstrated similar levels of expression of PSGL-1, CD43a, CD43c and L-selectin when compared to wild type cells (Table S1 ). Cells generated in this way were injected into unirradiated syngeneic wildtype mice followed by induction of peritoneal inflammation with or without their specific T cell antigen (ovalbumin) 19 . This model allows assessment of trafficking of the transferred cells independent of any defect in effector function that may be present in the T-bet -/-T cells and has been shown to be dependent upon both selectin 19 and chemokine mediated interactions 34 and S1). In fact the numbers of adoptively transferred cells was marginally higher in the spleen in the absence of T-bet (Fig. 1a,c) . Consistent with our previously published data 19 , there was substantial trafficking of transferred DO11.10 CD4 + T cells activated under Th1 conditions to the peritoneum (Fig. 1b,c) , whereas this migration was abrogated in DO11.10 x T-bet -/-CD4 + T cells (Fig. 1c) demonstrating a profound defect in proinflammatory T cell trafficking. This defect was similar in the presence or absence of antigen in the peritoneum, as we have previously demonstrated 19 .
T-bet -/-T cells exhibit impaired binding to P-selectin but not E-selectin.
Having observed a defect in migration of T cells to a peripheral inflammatory site in vivo, we postulated that T-bet -/-T cells might exhibit reduced interactions either with Eand/or P-selectin, or with specific Th1 chemokines. In order to assess this further, we T-bet -/-) mice were activated by antigen and antigen-presenting cells (Fig. 2b) .
T-bet CD2-transgenic mice exhibit increased selectin binding under Th2 polarization conditions.
In order to explore further the relationship between alterations in T-bet expression and T cell selectin binding, we analyzed CD4 + T cells purified from transgenic mice engineered to express T-bet under the control of the human CD2 promoter. The mice were produced by standard techniques and were bred onto the same background as all of the other transgenic strains used in this study (BALB/c). These mice (T-bet CD2-Tg)
expressed T-bet in a manner independent of their cytokine phenotype. Thus, CD2-Tg (Fig. 3a) . As would be predicted, CD2-Tg T cells produce more IFN-γ under unskewed (Th0) or Th1 conditions during primary activation, but ectopic T-bet expression was unable to drive IFN-γ production under Th2 polarizing conditions (Fig. 3b) during primary stimulation. However, T-bet expression did induce significant IFN-γ production under Th2 conditions after secondary stimulation (Fig. 3c) . There was no difference in IL-4 secretion between the T-bet CD2-Tg T cells and WT T cells after secondary stimulation (Fig. 3d) . Interestingly, whereas
Th1 cell binding to P-or E-selectin was unaffected by the presence of the T-bet transgene (Fig. 3e ), Th2 cells from T-bet CD2-Tg mice showed a marked increase in Pselectin binding (Fig. 3f) suggesting that T-bet directly induces selectin ligand expression. A small increase in binding of Th2 cells to E-selectin was also noted at low shear although this was considerably less marked than that observed with P-selectin.
There was no significant difference observed in the binding of T-bet CD2-Tg T cells to either selectin activated under unskewed conditions (not shown).
Impairment of P-selectin binding is due to a reduction in tyrosine sulfation of PSGL-1.
As binding to E-selectin was normal (a process critically dependent on fucosylation 35 ), it was unlikely that carbohydrate modification of PSGL-1 was responsible for the deficit observed in P-selectin binding. The alterations in binding to P-selectin occurred in the context of normal surface expression of PSGL-1 and the core-2 dependent epitope CD43a, as assessed by flow cytometry (Fig. 4a ) 26, 36 . Alterations in P-selectin binding of T cells from the T-bet CD2-Tg mice were also not likely due to changes in the cell surface markers CD43a, CD43c or PSGL-1 ( Table 1) . 13 was also similar for WT and T-bet -/-T-cells, as assessed by real time RT-PCR thus making a defect in either of these enzymes less likely (Fig. 4b) . We therefore tested whether defects in tyrosine sulfation of PSGL-1 were present in T-bet -/-cells to account for the specific reduction in binding to P-selectin 37 . Expression of tyrosyl protein sulfotransferase-1 (TPST-1) mRNA was the same in both WT and T-bet -/-Th1 cells, whereas a 50% reduction in the level of TPST-2 mRNA was observed in T-bet -/-Th1 cells (Fig. 4c) . There was no detectable increase in the mRNA levels of FucTVII in CD4 + T cells from the T-bet CD2-Tg mice (Fig. S2) , although there was an increase of TPST-1 and TPST-2 mRNA (Fig. S3) . Furthermore, we found that T-bet -/-CD4 + Th1 cells showed a substantial reduction of PSGL-1 tyrosine sulfation (Fig. 4d ). This reduction was independent of sulfation of glycosyl residues, because the difference in 35 S incorporation persisted even after removal of both O-and N-linked glycans (Fig.   4f ). These differences in tyrosine sulfation occurred in the context of similar levels of PSGL-1 between WT and T-bet -/-Th1 cells ( Fig. 4a and e) . Furthermore, densitometry showed some correlation between the reduction in sulfation and the levels of mRNA of TPST-2 ( Fig. 4c and d) . Chromatin IP experiments failed to detect direct binding of Tbet to the promoter of either TPST-1 or TPST-2 when the analysis was performed with primers spanning the first Kb of genomic DNA around the putative transcription start site (GML, LHG unpublished observations).
Expression and function of CXCR3 but not CCR5 is impaired in T-bet -/-T cells.
In addition to selectin ligand expression, CD4 + Th1 cell migration is dependent on chemokine receptor expression, notably CCR5 and CXCR3. In the absence of T-bet, levels of CXCR3 transcripts were minimal as compared to WT T cells activated under (Fig. 5a ). These changes were mirrored by surface expression of CXCR3 (Fig. 5b) , with no detectable receptor present on the T-bet -/-T cells. In contrast, T-bet CD2-Tg T cells expressed significantly more CXCR3 mRNA than WT T cells when activated under non-polarising or Th2 conditions (Fig. 5c) . Again, the transgenic overexpression of T-bet led to greater surface expression of CXCR3 in these cells (Fig. 5d) . Although these results suggest T-bet may directly regulate expression of CXCR3, its expression has also been reported to be regulated by IFN-γ 38 (Fig. 5f ). In marked contrast, levels of CCR5, the other Th1 selective chemokine receptor, were unaffected by the absence of T-bet (Fig. 5g) indicating selective regulation of a Th1 specific chemokine receptor by T-bet. The surface expression of CCR5 was similar on primary CD4 + T cells activated under Th1 polarising conditions on WT, T-bet -/-and T-bet -/-x IFN-γ -/-CD4 + T cells, with no detectable CCR5 on T cells of any genotype activated under Th2 polarizing conditions (Table S2) . Additionally, CCR5 mRNA levels were unchanged in T-bet CD2-Tg T cells (Fig. S4) . The expression of other chemokine receptors (e.g. CCR4, CXCR4, CCR7)
was also unchanged in the absence of T-bet. Chemokines also mediate activation of integrins, resulting in firm adhesion of rolling Tcells 27 , by inducing high-affinity or high-avidity states via a process of inside-out signalling 39 . To demonstrate a requirement for T-bet in this process, we observed the attachment of T cells to unstimulated cardiac endothelial cells (ECs) that had been treated with PBS or the CXCR3 ligand, CXCL10. In this system, all binding is dependent on β-integrin binding to VCAM-1 37 . In the absence of CXCL10, the binding of WT and T-bet -/-CD4 + Th1 cells was identical. In contrast, after the addition of CXCL10, only WT, and not T-bet -/-Th1 cells, showed increased attachment to ECs under conditions of physiological shear flow (Fig. 6d) . trafficking. We have shown that in the absence of T-bet, primary CD4 + T cells generated under Th1-polarising conditions fail to migrate appropriately in vivo due to defects in multiple specific mechanisms in the T cell trafficking pathway, including sulfation dependent P-selectin binding and CXCR3-dependent arrest and migration. Th2 cells from T-bet -/-mice also migrated less well to an inflammatory site in vivo, although this was not statistically significant and the relevance of this is unclear. Furthermore, it is entirely possible that further undiscovered mechanisms also contribute to the defective T cell trafficking that occurs in the absence of T-bet.
Of considerable interest with respect to selectin binding is the specificity of a P-selectin defect with preservation of E-selectin binding. It can therefore be inferred that certain Little is known about the control of these two critical enzymes but as the reduction in mRNA was not absolute, we postulate that the mechanism of T-bet control of tyrosine sulfation is unlikely to be at the transcriptional level. However, the expression and cellular location of these enzymes is exquisitely controlled. Active TPST's in the Golgi do, to a large degree, themselves require tyrosine sulfation in order to function effectively 41 and it remains a possibility that T-bet somehow modulates the post-translational functioning of either of these enzymes, more likely TPST-2 (see below). Furthermore, the relative contribution of these two enzymes to the sulfation of PSGL-1 has not been determined and will require further characterisation of mice deficient in one or both of these enzymes. Murine PSGL-1 differs from its human counterpart in certain respects, most pertinently that sulfation of only one of two tyrosine residues is required in mouse, compared to two out of three tyrosine residues in human [42] [43] [44] . Hence, any deficiency in sulfation might be magnified in human T-cells. Nevertheless, interruption in the function of either of these two enzymes represents an intriguing therapeutic strategy. [48] [49] [50] [51] . This finding has significant implications for the design of rational treatments for autoimmune, neoplastic and infectious diseases, and the prevention of rejection of transplanted organs. Results are expressed as mean ± s.e.m. 
